Navigation Links
Womb transplantation- to be successful in 2 years’ tim

The British doctors are hopeful that the world's first successful womb transplant operation will be carried out by them within 2 years.//

Women unable to have children because they are born without a uterus or have had to have an emergency hysterectomy will be benefited from this operation.

A new method to provide a transplanted womb with a reliable blood supply has been developed by a team of researchers at London, New York and Budapest.

In 2000, a 26-year-old Saudi woman underwent the world's first uterus transplant. But the operation failed when a clot developed in the blood vessel supplying the organ. This was the major problem, which has been overcome by the new procedure. It has been successful in animals and can be performed successfully in humans also.

Richard Smith, a consultant gynaecologist at Hammersmith Hospital in west London, said: "By getting to a place where we seem to have a reliable method of giving the uterus a blood supply, that takes us a whole heap closer to being able to provide this for humans."

Mr Smith and his team have been working on the project for eight years. They hope that transplantation of a womb from a dead donor to a woman unable to conceive will be possible soon.

He said: "We are relatively close. I think that two years probably is realistic. Two other groups of researchers - in Saudi Arabia and Sweden - are also working on human womb transplants. Already 30 women, most of them British, have expressed an interest in undergoing the procedure”, Mr Smith said.
GYT
'"/>




Page: 1

Related medicine news :

1. Endangered species may be successfully cloned in another animals womb
2. Indian Prime Minister has successful Knee Replacement Surgery
3. Hope for Marburg treatment: vaccine successful in primates
4. Down syndrome simulated in animal model after successful chromosome transplantation
5. AIDS bias successfully overcome by Indian Muslims in South Africa
6. Hunt for Common Genes linked to Cancer Expected to be Unsuccessful
7. China’s AIDS vaccine-successfully finishes first phas
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/31/2016)... ... 31, 2016 , ... The University of Tennessee Medical Center ... the latest in Clinical Patient Pod (CPP) technologies provided through Jvion’s ... into the clinical workflow. These insights are empowering the more than 30 case ...
(Date:5/31/2016)... Calif. (PRWEB) , ... May 31, 2016 , ... Effective ... colleagues, clients, and the industry as a whole. On June 2, Northbound CEO Mike ... on Addictive Disorders (WCSAD) and presenting the opening plenary on “Leadership: The Journey to ...
(Date:5/31/2016)... (PRWEB) , ... May 31, 2016 , ... ... planetary and numeral energies can describe personality traits in humans. Using presidential candidate ... behind their name and vitality. , “AstroNumerology is not about adding numbers ...
(Date:5/31/2016)... ... ... TeaZa® Energy, LLC announces the launch of a new limited ... . The new flavor—Tropical TeaZa? Energy—will be available to customers exclusively online starting ... flavor is best described as a juicy, taste bud takeover. A mouthwatering wave ...
(Date:5/31/2016)... ... May 31, 2016 , ... To ... solutions to the healthcare industry, The University of Scranton is adding a Certificate ... path to a career in rapidly growing field of healthcare information. , ...
Breaking Medicine News(10 mins):
(Date:5/26/2016)... -- Since its commercial introduction in 2005, ... science tool for conducting genetic studies in a range ... its new report that the industry sits on the ... a range of new applications in the clinical diagnostics ... ) , Since the Human Genome ...
(Date:5/25/2016)... -- According to a new market research ... by Therapeutic Area (Oncology, Cosmeceutical/Plastic Surgery), by Application (Drug ... Hospitals/ Clinics) - Forecast to 2021", published by MarketsandMarkets, ... the forecast period of 2016 to 2021. This market ... from USD 117.3 Million in 2016, at a CAGR ...
(Date:5/25/2016)... , Germany and ... QIAGEN N.V. (NASDAQ: QGEN ; Frankfurt Prime ... a licensing and co-development agreement with Therawis Diagnostics GmbH to ... will be to develop and market PITX2 as a marker ... other high-risk breast cancer patients. "We are pleased ...
Breaking Medicine Technology: